Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.

  • van Leeuwen
  • Konrad Kölble
  • Hartwig Huland
  • Hartwig Huland
  • Thomas Hambrock
  • Jelle Barentsz
  • Fritz H Schröder

Abstract

We addressed the question whether the change of serum prostate-specific antigen (PSA) in men who use 5?-reductase inhibitor (5-ARI) dutasteride is sensitive for the detection of aggressive prostate cancer (PCa).

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer2
ISSN0302-2838
StatusVeröffentlicht - 2011
pubmed 21130560